Frank Silver, MD
Gynecology · Las Vegas, NVNPI 1629097514
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 53.7% of the total. Reporting peaked in 2021 at $193 and has fallen 89.1% since, to $21 in 2025. That places this record below the midpoint for gynecology clinicians in NV, where the typical reported total is $1,013.
Across 12 payments — averaging $28.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$186
- Myovant Sciences Inc.$31
- Astellas Pharma US Inc$29
- AbbVie$23
- Redhill Biopharma Inc.$18
- Sumitomo Pharma America, Inc.$16
- plus $44 from 3 others
What the payments were for
- Food & beverage$33095%
- Education$165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 3 | $186 |
| Myovant Sciences Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| AbbVie | 1 | $23 |
| Redhill Biopharma Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$347 in reported general payments places this provider in the 35th percentile of 30 gynecology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 12 | $9,951 |
| Estradiol | 33 | $566 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $556 |
| Medroxyprogesterone Acetate | 32 | $449 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Las Vegas
- Duane AndersonLas Vegas$24K
- Barbara WotherspoonLas Vegas$5K
- Maribel MonroeLas Vegas$2K
- Anna ContomitrosLas Vegas$1K
- Toni Hodges WillsLas Vegas$1K
- Kayla RowlesLas Vegas$532
- Joseph EdwardsLas Vegas$341
- Robert ComeauLas Vegas$189
- Promise OjukwuLas Vegas$102
- Rafael DiazLas Vegas$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.